Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

The pathogenesis and clinical features of diabetic cardiomyopathy have been well-studied
in the past decade, but effective approaches to prevent and treat this disease are limited …

The coexistence of type 2 diabetes mellitus (T2DM) and heart failure (HF), either with
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) …

Background The aims of this study were to:(i) report the baseline characteristics of patients
enrolled in the Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA …

Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and
associated with considerable morbidity and mortality. Significant advances have recently …

Aims Patients with heart failure (HF) and with diabetes experienced significantly worse
outcomes than those without diabetes. However, data on the prognostic impact of …

The high incidence and poor prognosis of heart failure (HF) patients affected with diabetes
(DM) is in part related to a specific cardiac remodeling currently recognized as diabetic …

OBJECTIVE Several studies have explored the impact of diabetes on mortality in patients
with heart failure (HF). However, the extent to which diabetes may confer risk of mortality and …

Aim There is an association between heart failure with preserved ejection fraction (HFpEF)
and insulin resistance, but less is known about the diabetic continuum, and in particular …

Background: Worldwide, diabetes mellitus and heart failure represent frequent comorbidities
with high socioeconomic impact and steadily growing incidence, calling for a better …